BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6210531)

  • 21. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
    Li SC; Serizawa S; Li YT; Nakamura K; Handa S
    J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of GM2 activator protein with glycosphingolipids.
    Hama Y; Li YT; Li SC
    J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.
    Hasilik A; von Figura K; Conzelmann E; Nehrkorn H; Sandhoff K
    Eur J Biochem; 1982 Jul; 125(2):317-21. PubMed ID: 6214395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activator proteins for lysosomal glycolipid hydrolysis.
    Conzelmann E; Sandhoff K
    Methods Enzymol; 1987; 138():792-815. PubMed ID: 2885714
    [No Abstract]   [Full Text] [Related]  

  • 25. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycosphingolipid specificity of the human sulfatide activator protein.
    Vogel A; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
    J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
    Aronovich EL; Akhunov VS; Krasnopol'skaia KD
    Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
    Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
    Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
    Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
    J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enzyme-binding region of human GM2-activator protein.
    Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
    FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of glycolipids by water-soluble lysosomal glycosidases.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Adv Exp Med Biol; 1982; 152():227-33. PubMed ID: 7136911
    [No Abstract]   [Full Text] [Related]  

  • 38. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
    Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
    J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
    Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.